top of page

The CEO of Lyndra Therapeutics describes the company's technology that turns daily pills into weekly ones - and potentially longer

  • blonca9
  • Dec 9, 2024
  • 1 min read

Jessica Ballinger describes the science behind this and how an extended release format can improve health outcomes. Plus, the progress Lyndra has made developing a risperidone based product, and other areas this might be used for.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen_Logo_RGB.png

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page